S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Sangamo TherapeuticsRegenxbioEditas MedicineMomenta PharmaceuticalsFate Therapeutics
SymbolNASDAQ:SGMONASDAQ:RGNXNASDAQ:EDITNASDAQ:MNTANASDAQ:FATE
Price Information
Current Price$8.32$37.75$19.73$14.40$13.63
52 Week RangeHoldBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$14.00$79.13$38.00$23.63$25.00
% Upside from Price Target68.37% upside109.60% upside92.60% upside64.10% upside83.42% upside
Trade Information
Market Cap$987.91 million$1.39 billion$999.52 million$1.42 billion$954.69 million
Beta2.810.822.492.031.79
Average Volume1,865,797561,846781,303525,453737,596
Sales & Book Value
Annual Revenue$84.45 million$218.51 million$31.94 million$75.59 million$4.74 million
Price / Sales11.396.3630.5918.80188.02
CashflowN/A$2.57 per shareN/AN/AN/A
Price / CashN/A14.68N/AN/AN/A
Book Value$3.60 per share$14.20 per share$4.94 per share$4.68 per share$2.48 per share
Price / Book2.312.663.993.085.50
Profitability
Net Income$-68,330,000.00$99.94 million$-109,950,000.00$-176,060,000.00$-66,600,000.00
EPS($0.70)$2.38($2.33)($2.03)($1.19)
Trailing P/E RatioN/A15.86N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-136.73%-88.57%-412.70%-324.41%-934.70%
Return on Equity (ROE)-27.32%-15.39%-47.46%-55.24%-50.05%
Return on Assets (ROA)-17.23%-14.50%-26.79%-41.51%-35.63%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.01%0.07%N/A0.28%
Current Ratio5.63%14.58%4.45%7.59%5.61%
Quick Ratio5.63%14.58%4.45%7.59%5.61%
Ownership Information
Institutional Ownership Percentage69.02%79.48%79.16%96.29%96.59%
Insider Ownership Percentage1.30%13.80%0.94%3.40%23.19%
Miscellaneous
Employees302192133131104
Shares Outstanding115.68 million36.81 million49.52 million98.71 million65.39 million
Next Earnings Date11/14/2019 (Estimated)11/6/2019 (Estimated)11/6/2019 (Estimated)11/6/2019 (Estimated)11/7/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 Sangamo TherapeuticsRegenxbioEditas MedicineMomenta PharmaceuticalsFate Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel